Cours Alterola Biotech, Inc. Other OTC
Actions
ABTI
US02152V1035
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 35,27 M 32,21 M |
---|---|---|---|---|---|
Résultat net 2022 | -6 M -5,48 M | Résultat net 2023 | -1 M -913 k | VE / CA 2022 | - |
Dette nette 2022 | 199 k 182 k | Dette nette 2023 | 1,41 M 1,28 M | VE / CA 2023 | - |
PER 2022 |
-26,2
x | PER 2023 |
-20,2
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 56,4% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 18/05/22 |
Timothy Rogers
CHM | Chairman | 60 | 21/06/21 |
Colin Stott
COO | Chief Operating Officer | 57 | 21/06/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 18/05/22 |
Nathan Thompson
BRD | Director/Board Member | - | 10/10/23 |
Daniel Reshef
BRD | Director/Board Member | 73 | - |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,31% | 103 Md | |
+0,56% | 95,28 Md | |
+1,69% | 22,15 Md | |
-17,37% | 21,02 Md | |
-9,30% | 18,15 Md | |
-41,01% | 16,74 Md | |
-14,85% | 16,05 Md | |
+3,21% | 13,68 Md | |
+33,54% | 12,17 Md |